Jennifer Doudna spinoff aims to turn patients’ immune cells into CAR-T fighters with single shot Azalea Therapeutics raises $82 million, pursuing in vivo CAR-T for cancer and autoimmune disease

https://www.statnews.com/2025/11/04/jennifer-doudna-biotech-azalea-therapeutics-raises-82-million/